Company Filing History:
Years Active: 1997
Title: Lynette Overacre: Innovator in Antiestrogen and Anti-Tumor Compounds
Introduction
Lynette Overacre is a notable inventor based in Norman, OK (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as antiestrogens and anti-tumor agents. With a total of three patents to her name, Overacre's work is recognized for its potential impact on cancer treatment.
Latest Patents
Among her latest patents are the Diphenylcyclopropyl analogs. These compounds feature one or more phenyl rings that include alkoxy substituents, such as a dialkylaminoalkoxy group, an unsubstituted piperazine alkoxy group, a substituted piperazine alkoxy group, an unsubstituted piperidine alkoxy group, and a substituted piperidine alkoxy group. Additionally, these compounds may have one or two alkyl groups bonded to the cyclopropane. The innovative nature of these compounds lies in their utility as antiestrogens and anti-tumor agents.
Career Highlights
Lynette Overacre is currently associated with Research Corporation Technologies, Inc., where she continues to advance her research and development efforts. Her work has garnered attention in the scientific community, particularly for its implications in cancer therapy.
Collaborations
Overacre collaborates with esteemed colleagues, including Robert A. Magarian and Joseph T. Pento. Their combined expertise contributes to the innovative research being conducted at their institution.
Conclusion
Lynette Overacre stands out as a pioneering inventor in the realm of pharmaceuticals, with her work on Diphenylcyclopropyl analogs showcasing her commitment to advancing cancer treatment. Her contributions are vital to the ongoing fight against cancer, and her innovative spirit continues to inspire others in the field.